BEVYXXA (Portola Pharmaceuticals, Inc.)


Welcome to the PulseAid listing for the BEVYXXA drug offered from Portola Pharmaceuticals, Inc.. This Factor Xa Inhibitors [MoA],Factor Xa Inhibitor [EPC] pharmaceutical is classified as a HUMAN PRESCRIPTION DRUG. Below, you can view details for this drug, such as its dosage form, route of delivery, start market/end market dates, and more. We have also randomly listed additional pharmaceuticals used in the same HUMAN PRESCRIPTION DRUG drug type category.
LABELER NAME / MANUFACTURER: Portola Pharmaceuticals, Inc.
NON-PROPRIETARY NAME: betrixaban
SUBSTANCE NAME: BETRIXABAN
TYPE: HUMAN PRESCRIPTION DRUG
PHARMA CLASS: Factor Xa Inhibitors [MoA],Factor Xa Inhibitor [EPC]
ROUTE: ORAL
DOSAGE FORM: CAPSULE, GELATIN COATED
MARKETING CATEGORY NAME: NDA
START MARKETING DATE: 2017-07-07
END MARKETING DATE: 0000-00-00


BEVYXXA HUMAN PRESCRIPTION DRUG Details:

Item DescriptionBEVYXXA from Portola Pharmaceuticals, Inc.
LABELER NAME: Portola Pharmaceuticals, Inc.
DEA SCHEDULE:
ACTIVE STRENGTH: 80(mg/1)
START MARKETING DATE: 2017-07-07
END MARKETING DATE: 0000-00-00
PRODUCT ID: 69853-0201_5e825dd0-d74c-4826-9235-a3bf5d07db42
PRODUCT NDC: 69853-0201
APPLICATION NUMBER: NDA208383

Other BETRIXABAN Pharmaceutical Manufacturers / Labelers:

Manufacturer / LabelerProprietary Name
Portola Pharmaceuticals, Inc.BEVYXXA